The Armchair Analyst

The Armchair Analyst

5-minute daily updates on the ASX life-sciences sector.

Recent Articles

Why are Tetratherix (ASX: TTX) shares moving?

Why are Tetratherix (ASX: TTX) shares moving?

May 25, 2026

•

5 min read

Escaping the Billing Graveyard: The Pacific Edge Story (ASX: PEB)

Escaping the Billing Graveyard: The Pacific Edge Story (ASX: PEB)

May 22, 2026

•

9 min read

Why Change Management Matters More Than AI in Healthcare

Why Change Management Matters More Than AI in Healthcare

May 21, 2026

•

5 min read

Vital Signs: Live from Digital Health Festival

Vital Signs: Live from Digital Health Festival

May 20, 2026

•

2 min read

The Anatomy of a Short Squeeze

The Anatomy of a Short Squeeze

May 19, 2026

•

6 min read

Bet on the Hare, Get the Tortoise: Clinuvel’s Story (ASX: CUV)

Bet on the Hare, Get the Tortoise: Clinuvel’s Story (ASX: CUV)

May 18, 2026

•

11 min read

Don’t cook the float

Don’t cook the float

May 15, 2026

•

2 min read

Innovation Decimation: Budget to Break Biotech

Innovation Decimation: Budget to Break Biotech

May 14, 2026

•

2 min read

The "Kate Bush" Trade: Acrux's (ASX: ACR) Story

The "Kate Bush" Trade: Acrux's (ASX: ACR) Story

May 13, 2026

•

7 min read

Not Your Typical Biotech Shed

Not Your Typical Biotech Shed

May 11, 2026

•

4 min read

The Slow Death of Risk Capital

The Slow Death of Risk Capital

May 8, 2026

•

3 min read

Spray and Pray: How J&J grew a US$2.3b drug from a three-year bad trip

Spray and Pray: How J&J grew a US$2.3b drug from a three-year bad trip

May 7, 2026

•

6 min read

...